Research: Availability of evidence of benefits on overall survival and quality of life of cancer drugs

Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13 – The BMJ (free)

Editorials: Do cancer drugs improve survival or quality of life? (free) AND Cancer drugs: high price, uncertain value (free)

Commentaries: Over half of new cancer drugs ‘show no benefits’ for survival or wellbeing – The Guardian (free) AND Only half of new cancer drugs extend or improve life – OnMedica (free) AND Some cancer drugs approved in Europe might not have sufficient evidence of survival benefits, says study – Cancer Research UK (free)